title: Side effects and complications of treatment with desmopressin for enuresis.
abstract: A literature search revealed 23 studies that have reported on the type or frequency of side effects or complications associated with the use of desmopressin (DDAVP, Rhône-Poulenc Rorer Pharmaceuticals Inc, Collegeville, Pennsylvania) for the treatment of enuresis. Thirty-one (4.3%) side effects were reported in 717 patients. Seizure secondary to water intoxication is a potential complication of treatment with desmopressin and was reported in six patients, usually in association with excess fluid intake during the evening or day preceding the use of desmopressin. Desmopressin appears to have a favorable safety profile. Patients should be specifically instructed not to ingest excess fluids during the evening prior to administration of desmopressin.
authors: Division of Pediatric Nephrology, Children's Hospital, Calgary, Alberta, Canada.
authors: W L
authors: WL
authors: Robson
authors: A K
authors: AK
authors: Leung
mesh_terms: D002986:Clinical Trials as Topic; D003894:Deamino Arginine Vasopressin / Q000009:adverse effects*; D004326:Drinking; D004775:Enuresis / Q000188:drug therapy*; D006801:Humans; D015201:Meta-Analysis as Topic; D012640:Seizures / Q000139:chemically induced; D014869:Water Intoxication / Q000139:chemically induced
chemical_list: D003894:Deamino Arginine Vasopressin